Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...

Immunocore has an EV/Sales ratio of 2.53X, which is below a sector median of 3.58x and represents a discount of approximately ...

Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles.

Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...